Outsourcing specialists offer enhanced services
A collaboration between London-based Pharmaterials and Penn Pharmaceutical Services in South Wales will enable virtual, small and medium-sized pharmaceutical companies to progress investigational medicinal products through to clinical trials manufacture, using a wide variety of materials characterisation, preformulation and formulation techniques.
A collaboration between London-based Pharmaterials and Penn Pharmaceutical Services in South Wales will enable virtual, small and medium-sized pharmaceutical companies to progress investigational medicinal products through to clinical trials manufacture, using a wide variety of materials characterisation, preformulation and formulation techniques.
Clients will have the opportunity to combine state-of-the art analytical techniques for materials characterisation and product development offered by Pharmaterials with the larger scale, GMP compliant, formulation development, clinical manufacturing and stability monitoring functions offered by Penn.
Dr Chris Higgins, director of business development, Penn, said: 'Penn has a strong track record in conducting formulation development projects to the required GMP standards for virtual, small and medium-sized pharmaceutical companies. Through our partnership with Pharmaterials we can now add a host of specialist services for solid-form r&d and preformulation screening, thereby operating a seamless process from project concept as far as contract manufacture.'